Therefore this study aimed to investigate the diagnostic performance of the anti-CCP3.1 assay in comparison to anti-CCP2 IgG and IgA assays in patients with early RA and an appropriate number of disease controls. Here, AGBL3 is linked to rheumatoid arthritis.